Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Human Surfactant Protein A Alleviates SARS-CoV-2 Infectivity in Human Lung Epithelial Cells

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.03.535215Source: DataRank Database

Human Surfactant Protein A Alleviates SARS-CoV-2 Infectivity in Human Lung Epithelial Cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Amanda Gemmiti ORCID,Weichuan Xiong ORCID,Erin S. Reynolds ORCID,Brian D. Nicholas ORCID,Saravanan Thangamani ORCID

Live enrichment

PubMed:37066146 OpenAlex:https://openalex.org/W4362666750

National Science Foundation

Grant: 1722630

SCH: INT: Collaborative Research: Crowd in Action: Human-Centric Privacy-Preserving Data Analytics for Environmental Public Health

National Institutes of Health

Grant: 3R21AI149321-01S1

New ACE2 activator and its prodrug as novel therapeutic reagents for inflammatory pulmonary diseases

National Institutes of Health

Grant: 5R21AI171574-02

Roles of human surfactant collectin variants in the susceptibility of COVID-19

National Institutes of Health

Grant: 5R01HL136706-04

Mechanisms of differential susceptibility of human SP-B genetic variants to pneumonia and lung injury

National Institutes of Health

Grant: 1R01AI148446-01A1

The role of ACE2 in Influenza viral infection mediated immune compromise and subsequent bacterial lung infection

NHLBI NIH HHS

Grant: R01 HL136706

NIAID NIH HHS

Grant: R21 AI171574

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/04/03/2023.04.03.535215.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.04.03.535215

repositoryhttps://doi.org/10.1101/2023.04.03.535215

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37066146

Fields of Study

Neonatal Respiratory Health ResearchRespiratory Support and MechanismsChronic Obstructive Pulmonary Disease (COPD) Research0301 basic medicine03 medical and health sciences

Keywords

InfectivityPulmonary surfactantHuman lungSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologySars virus2019-20 coronavirus outbreakLungBetacoronavirusChemistryBiologyMedicineVirusPathologyBiochemistryInternal medicineInfectious disease (medical specialty)Disease

Sustainable Development Goals

SDG 0: Good health and well-being